Russia to make Viagra replacement after US manufacturer halted supplies

Russia's industry and trade ministry is scrambling to produce a replacement for Viagra, after the U.S. manufacturer of the popular erectile dysfunction remedy halted supplies last year.To get more news about 正品犀利士哪裡買, you can visit our official website.

The U.S. pharmaceutical company Viatris, a spinoff of Pfizer, announced that it would halt planned investments and all clinical trials in Russia shortly after the invasion of Ukraine, but continued to supply critical medicines. "In 2022 Viatris LLC informed about suspension of supplies of Viagra in dosage form of a tablet," the trade ministry said.

To make up for the suspension, the Kremlin has been supporting clinical trials in the country. Based on their results, the ministry told Interfax on Wednesday, that Russian companies have the "technological possibility" to manufacture generic medication that contains the substance called Sildenafil, sold under the brand name Viagra.
Thirty-six Russian companies had been issued registration certificates to produce a Russian erectile dysfunction pill, which appears to be high in demand.

Studies cited by the Kommersant business daily say Russians bought 2.7 million erectile dysfunction pills in mid-2022, an 88 percent jump from the same time in 2021.

In the first three quarters of 2022, the production of drugs containing Sildenafil increased by more than 11 percent, while sales increased by more than 15 percent in the same period, Interfax reported.

Russia's health ministry said pharmacies are not experiencing shortages when it comes to the generic drug.

Sanctions levied by the United States, Britain, the European Union and others against Russia do not apply to medicine and medical equipment, but Western pharmaceutical companies warned early on that supplying medicine may be complicated by economic sanctions targeting the country and its major banks, and many companies have voluntarily reduced or ended their business dealings in Russia.